203 related articles for article (PubMed ID: 31321410)
1. Inappropriate Empirical Antibiotic Treatment in High-risk Neutropenic Patients With Bacteremia in the Era of Multidrug Resistance.
Martinez-Nadal G; Puerta-Alcalde P; Gudiol C; Cardozo C; Albasanz-Puig A; Marco F; Laporte-Amargós J; Moreno-García E; Domingo-Doménech E; Chumbita M; Martínez JA; Soriano A; Carratalà J; Garcia-Vidal C
Clin Infect Dis; 2020 Mar; 70(6):1068-1074. PubMed ID: 31321410
[TBL] [Abstract][Full Text] [Related]
2. Resistance to empirical β-lactams recommended in febrile neutropenia guidelines in Gram-negative bacilli bloodstream infections in Spain: a multicentre study.
Chumbita M; Puerta-Alcalde P; Yáñez L; Cuesta MA; Chinea A; Español Morales I; Fernández Abellán P; Gudiol C; Guerreiro M; González-Sierra P; Rojas R; Sánchez Pina JM; Sánchez Vadillo I; Varela R; Vázquez L; Lopera C; Monzó P; Garcia-Vidal C
J Antimicrob Chemother; 2022 Jun; 77(7):2017-2023. PubMed ID: 35466357
[TBL] [Abstract][Full Text] [Related]
3. High Rate of Inappropriate Antibiotics in Patients with Hematologic Malignancies and Pseudomonas aeruginosa Bacteremia following International Guideline Recommendations.
Chumbita M; Puerta-Alcalde P; Yáñez L; Angeles Cuesta M; Chinea A; Español-Morales I; Fernandez-Abellán P; Gudiol C; González-Sierra P; Rojas R; Sánchez-Pina JM; Vadillo IS; Sánchez M; Varela R; Vázquez L; Guerreiro M; Monzo P; Lopera C; Aiello TF; Peyrony O; Soriano A; Garcia-Vidal C
Microbiol Spectr; 2023 Aug; 11(4):e0067423. PubMed ID: 37367629
[TBL] [Abstract][Full Text] [Related]
4. Impact of Empirical Antibiotic Regimens on Mortality in Neutropenic Patients with Bloodstream Infection Presenting with Septic Shock.
Chumbita M; Puerta-Alcalde P; Gudiol C; Garcia-Pouton N; Laporte-Amargós J; Ladino A; Albasanz-Puig A; Helguera C; Bergas A; Grafia I; Sastre E; Suárez-Lledó M; Durà X; Jordán C; Marco F; Condom M; Castro P; Martínez JA; Mensa J; Soriano A; Carratalà J; Garcia-Vidal C
Antimicrob Agents Chemother; 2022 Feb; 66(2):e0174421. PubMed ID: 34843387
[TBL] [Abstract][Full Text] [Related]
5. Changing epidemiology of bloodstream infection in a 25-years hematopoietic stem cell transplant program: current challenges and pitfalls on empiric antibiotic treatment impacting outcomes.
Puerta-Alcalde P; Cardozo C; Marco F; Suárez-Lledó M; Moreno E; Morata L; Fernández-Avilés F; Gutiérrez-Garcia G; Chumbita M; Rosiñol L; Martínez JA; Martínez C; Mensa J; Urbano Á; Rovira M; Soriano A; Garcia-Vidal C
Bone Marrow Transplant; 2020 Mar; 55(3):603-612. PubMed ID: 31570779
[TBL] [Abstract][Full Text] [Related]
6.
Royo-Cebrecos C; Laporte-Amargós J; Peña M; Ruiz-Camps I; Puerta-Alcalde P; Abdala E; Oltolini C; Akova M; Montejo M; Mikulska M; Martín-Dávila P; Herrera F; Gasch O; Drgona L; Morales HMP; Brunel AS; García E; Isler B; Kern WV; Palacios-Baena ZR; de la Calle GM; Montero MM; Kanj SS; Sipahi OR; Calik S; Márquez-Gómez I; Marin JI; Gomes MZR; Hemmatti P; Araos R; Peghin M; Del Pozo JL; Yáñez L; Tilley R; Manzur A; Novo A; Carratalà J; Gudiol C;
Pathogens; 2022 Sep; 11(10):. PubMed ID: 36297188
[TBL] [Abstract][Full Text] [Related]
7. Effect of Combination Antibiotic Empirical Therapy on Mortality in Neutropenic Cancer Patients with
Albasanz-Puig A; Durà-Miralles X; Laporte-Amargós J; Mussetti A; Ruiz-Camps I; Puerta-Alcalde P; Abdala E; Oltolini C; Akova M; Montejo JM; Mikulska M; Martín-Dávila P; Herrera F; Gasch O; Drgona L; Morales HMP; Brunel AS; García E; Isler B; Kern WV; Retamar-Gentil P; Aguado JM; Montero M; Kanj SS; Sipahi OR; Calik S; Márquez-Gómez I; Marin JI; Gomes MZR; Hemmati P; Araos R; Peghin M; Del Pozo JL; Yáñez L; Tilley R; Manzur A; Novo A; Pallarès N; Bergas A; Carratalà J; Gudiol C; On Behalf Of The Ironic Study Group
Microorganisms; 2022 Mar; 10(4):. PubMed ID: 35456784
[TBL] [Abstract][Full Text] [Related]
8. Current time-to-positivity of blood cultures in febrile neutropenia: a tool to be used in stewardship de-escalation strategies.
Puerta-Alcalde P; Cardozo C; Suárez-Lledó M; Rodríguez-Núñez O; Morata L; Fehér C; Marco F; Del Río A; Martínez JA; Mensa J; Rovira M; Esteve J; Soriano A; Garcia-Vidal C
Clin Microbiol Infect; 2019 Apr; 25(4):447-453. PubMed ID: 30096417
[TBL] [Abstract][Full Text] [Related]
9. Risk Factors for Mortality in Hematopoietic Stem Cell Transplantation Recipients with Bloodstream Infection: Points To Be Addressed by Future Guidelines.
Puerta-Alcalde P; Chumbita M; Charry P; Castaño-Díez S; Cardozo C; Moreno-García E; Marco F; Suárez-Lledó M; Garcia-Pouton N; Morata L; Fernández-Avilés F; Martínez-Roca A; Rodríguez G; Martínez JA; Martínez C; Mensa J; Urbano Á; Rovira M; Soriano A; Garcia-Vidal C
Transplant Cell Ther; 2021 Jun; 27(6):501.e1-501.e6. PubMed ID: 33891882
[TBL] [Abstract][Full Text] [Related]
10. Risk Factors and Outcomes of Antibiotic-resistant Pseudomonas aeruginosa Bloodstream Infection in Adult Patients With Acute Leukemia.
Zhao Y; Lin Q; Liu L; Ma R; Chen J; Shen Y; Zhu G; Jiang E; Mi Y; Han M; Wang J; Feng S
Clin Infect Dis; 2020 Dec; 71(Suppl 4):S386-S393. PubMed ID: 33367574
[TBL] [Abstract][Full Text] [Related]
11. Real-Life Use of Ceftolozane/Tazobactam for the Treatment of Bloodstream Infection Due to Pseudomonas aeruginosa in Neutropenic Hematologic Patients: a Matched Control Study (ZENITH Study).
Bergas A; Albasanz-Puig A; Fernández-Cruz A; Machado M; Novo A; van Duin D; Garcia-Vidal C; Hakki M; Ruiz-Camps I; Del Pozo JL; Oltolini C; DeVoe C; Drgona L; Gasch O; Mikulska M; Martín-Dávila P; Peghin M; Vázquez L; Laporte-Amargós J; Durà-Miralles X; Pallarès N; González-Barca E; Álvarez-Uría A; Puerta-Alcalde P; Aguilar-Company J; Carmona-Torre F; Clerici TD; Doernberg SB; Petrikova L; Capilla S; Magnasco L; Fortún J; Castaldo N; Carratalà J; Gudiol C
Microbiol Spectr; 2022 Jun; 10(3):e0229221. PubMed ID: 35475683
[TBL] [Abstract][Full Text] [Related]
12. Clinical Predictive Model of Multidrug Resistance in Neutropenic Cancer Patients with Bloodstream Infection Due to Pseudomonas aeruginosa.
Gudiol C; Albasanz-Puig A; Laporte-Amargós J; Pallarès N; Mussetti A; Ruiz-Camps I; Puerta-Alcalde P; Abdala E; Oltolini C; Akova M; Montejo M; Mikulska M; Martín-Dávila P; Herrera F; Gasch O; Drgona L; Paz Morales H; Brunel AS; García E; Isler B; Kern WV; Morales I; Maestro-de la Calle G; Montero M; Kanj SS; Sipahi OR; Calik S; Márquez-Gómez I; Marin JI; Gomes MZR; Hemmatti P; Araos R; Peghin M; Del Pozo JL; Yáñez L; Tilley R; Manzur A; Novo A; Carratalà J;
Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 32015035
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology and risk factors for recurrence in biliary source bloodstream infection episodes in oncological patients.
Grafia I; Chumbita M; Seguí E; Cardozo C; Laguna JC; García de Herreros M; Garcia-Pouton N; Villaescusa A; Pitart C; Rico-Caballero V; Marco-Hernández J; Zamora C; Viladot M; Padrosa J; Tuca A; Mayor-Vázquez E; Marco F; Martínez JA; Mensa J; Garcia-Vidal C; Soriano A; Puerta-Alcalde P
Microbiol Spectr; 2023 Aug; 11(5):e0214223. PubMed ID: 37610217
[TBL] [Abstract][Full Text] [Related]
14. Bloodstream infections in patients with solid tumors: epidemiology, antibiotic therapy, and outcomes in 528 episodes in a single cancer center.
Marín M; Gudiol C; Garcia-Vidal C; Ardanuy C; Carratalà J
Medicine (Baltimore); 2014 May; 93(3):143-149. PubMed ID: 24797169
[TBL] [Abstract][Full Text] [Related]
15. Dissecting bloodstream infections in febrile neutropenic patients with hematological malignancies, a decade-long single center retrospective observational study (2009-2019).
El Omri H; Padmanabhan R; Taha RY; Kassem N; Elsabah H; Ellahie AY; Santimano AJJ; Al-Maslamani MA; Omrani AS; Elomri A; El Omri A
J Infect Public Health; 2024 Jan; 17(1):152-162. PubMed ID: 38029491
[TBL] [Abstract][Full Text] [Related]
16. Clinical characteristics and outcomes of Pseudomonas aeruginosa bacteremia in febrile neutropenic children and adolescents with the impact of antibiotic resistance: a retrospective study.
Kim HS; Park BK; Kim SK; Han SB; Lee JW; Lee DG; Chung NG; Cho B; Jeong DC; Kang JH
BMC Infect Dis; 2017 Jul; 17(1):500. PubMed ID: 28716109
[TBL] [Abstract][Full Text] [Related]
17. Guidance of empirical antimicrobial therapy by surveillance cultures in high-risk neutropenic patients: a retrospective cohort study.
de la Court JR; Heijmans J; Huynh J; Sieswerda E; de Jonge NA; van Dijk K; Sigaloff KCE; Schade RP
Antimicrob Resist Infect Control; 2022 Dec; 11(1):160. PubMed ID: 36529742
[TBL] [Abstract][Full Text] [Related]
18. Rates, predictors and mortality of community-onset bloodstream infections due to Pseudomonas aeruginosa: systematic review and meta-analysis.
Rojas A; Palacios-Baena ZR; López-Cortés LE; Rodríguez-Baño J
Clin Microbiol Infect; 2019 Aug; 25(8):964-970. PubMed ID: 30995530
[TBL] [Abstract][Full Text] [Related]
19. Determinants of inappropriate empirical antibiotic treatment: systematic review and meta-analysis.
Carrara E; Pfeffer I; Zusman O; Leibovici L; Paul M
Int J Antimicrob Agents; 2018 Apr; 51(4):548-553. PubMed ID: 29277528
[TBL] [Abstract][Full Text] [Related]
20. Influence of multidrug resistance and appropriate empirical therapy on the 30-day mortality rate of Pseudomonas aeruginosa bacteremia.
Morata L; Cobos-Trigueros N; Martínez JA; Soriano A; Almela M; Marco F; Sterzik H; Núñez R; Hernández C; Mensa J
Antimicrob Agents Chemother; 2012 Sep; 56(9):4833-7. PubMed ID: 22751533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
